TOLVAPTAN 45MG TABLET by CCL PHARMA contains Tolvaptan 45MG, a prescription vasopressin V2-receptor antagonist that works on the kidneys to regulate water balance. Tolvaptan promotes the removal of excess free water and is used in specific medical conditions under close medical supervision.
The 45MG strength may be used as part of a condition-specific dosing regimen, particularly in certain treatment protocols for autosomal dominant polycystic kidney disease (ADPKD). Tolvaptan may also be used in selected cases of hyponatremia, but dosing differs by indication. It is important to use this medicine only according to your doctor's prescription.
✔️ Promotes Free-Water Excretion – Helps the kidneys remove excess water by blocking vasopressin V2 receptors.
✔️ Supports Fluid Balance – Helps regulate abnormal water retention in appropriately selected patients.
✔️ Used in ADPKD Treatment – Tolvaptan is used in selected adults with rapidly progressing autosomal dominant polycystic kidney disease where approved and clinically appropriate.
✔️ Helps Slow Kidney-Cyst Progression – In appropriate ADPKD patients, long-term Tolvaptan treatment can slow the increase in kidney volume and decline in kidney function.
✔️ Used in Selected Hyponatremia Cases – Tolvaptan can increase serum sodium in certain patients with clinically significant hyponatremia, although the dosing regimen is different from ADPKD treatment.
✔️ Targeted V2-Receptor Action – Specifically blocks vasopressin signaling involved in kidney water reabsorption.
✔️ Oral Tablet Form – Convenient administration when prescribed by a healthcare professional.
Tolvaptan selectively blocks the vasopressin V2 receptor in the kidney.
Normally, vasopressin signals the kidneys to retain water. By blocking this receptor, Tolvaptan reduces water reabsorption.
💧 Vasopressin
⬇️
🧬 V2 receptor in kidney
⬇️
💦 Water reabsorption
Tolvaptan blocks the V2 receptor
⬇️
💧 Increased free-water excretion
⬇️
⚖️ Improved water balance
In ADPKD, vasopressin signaling also contributes to pathways involved in kidney-cyst growth. By blocking V2 receptors, Tolvaptan can help slow disease progression in appropriately selected patients.
Autosomal dominant polycystic kidney disease (ADPKD) is an inherited kidney disorder in which multiple fluid-filled cysts develop in the kidneys.
Over time, these cysts can enlarge the kidneys and may contribute to progressive loss of kidney function.
Tolvaptan may be prescribed for selected adults with rapidly progressing ADPKD.
Potential treatment benefits include:
✔️ Slowing kidney-volume increase
✔️ Slowing decline in kidney function
✔️ Supporting longer-term kidney health in appropriate patients
⚠️ Tolvaptan is not suitable for every person with ADPKD. Your nephrologist determines whether treatment is appropriate based on kidney function, disease progression, age, and other factors.
Tolvaptan can also be used for certain forms of hyponatremia (low blood sodium).
It increases the elimination of free water, which can raise serum sodium in appropriately selected patients.
However, the dosing regimen for hyponatremia is different from the regimen used for ADPKD.
Therefore, TOLVAPTAN 45MG should not be self-used for low sodium.
🌟 Contains Tolvaptan 45MG – A selective vasopressin V2-receptor antagonist.
🫘 Important Role in Selected ADPKD Patients – May slow disease progression when prescribed to appropriate patients.
💧 Promotes Aquaresis – Helps the kidneys remove free water.
🧬 Targeted V2-Receptor Mechanism – Acts on a specific vasopressin pathway.
💊 Convenient Tablet Form – Oral administration according to a prescribed treatment schedule.
🏭 CCL PHARMA – Product supplied under the CCL PHARMA brand.
📦 10-Tablet Pack – Convenient pack size.
⚠️ Take TOLVAPTAN exactly as prescribed by your doctor.
✔️ Swallow the tablet with water.
✔️ It can generally be taken with or without food.
✔️ Follow the prescribed dosing schedule carefully.
✔️ Do not change the dose yourself.
✔️ Do not substitute the 45MG strength for another Tolvaptan strength without medical advice.
✔️ Maintain adequate access to water because Tolvaptan can substantially increase thirst and urination.
For ADPKD, Tolvaptan treatment commonly uses a split-dose regimen, with the exact doses determined and adjusted by a specialist.
The appropriate regimen can depend on:
🫘 Kidney function
🧪 Liver function
📈 Rate of disease progression
💊 Other medicines
💧 Fluid balance
👤 Individual patient factors
Do not assume that one 45MG tablet represents your complete daily dose. Follow your prescription exactly.
Long-term Tolvaptan treatment, particularly in ADPKD, can cause potentially serious liver injury.
Your doctor may require regular liver-function tests before and during treatment.
Contact your healthcare professional if you develop:
🚨 Extreme tiredness
🚨 Loss of appetite
🚨 Nausea or vomiting
🚨 Dark urine
🚨 Yellow skin or eyes
🚨 Upper abdominal discomfort
Tolvaptan increases water excretion and can cause significant dehydration.
Possible symptoms include:
🔹 Excessive thirst
🔹 Dry mouth
🔹 Dizziness
🔹 Weakness
🔹 Reduced urination
🔹 Dark-colored urine
Patients taking Tolvaptan should have access to sufficient water and follow their doctor's fluid instructions.
Tolvaptan can significantly change serum sodium.
If it is being used to treat hyponatremia, sodium may rise too quickly, potentially causing serious neurological complications.
⚠️ Do not use Tolvaptan for low sodium without appropriate medical supervision and laboratory monitoring.
Possible side effects may include:
✔️ Increased thirst
✔️ Increased urination
✔️ Dry mouth
✔️ Frequent urination
✔️ Dizziness
✔️ Dehydration
✔️ Changes in sodium levels
✔️ Fatigue
In ADPKD treatment, increased urination and thirst are particularly common because the medicine intentionally increases water excretion.
🚨 Severe dehydration
🚨 Fainting
🚨 Severe confusion
🚨 Seizures
🚨 Yellowing of the skin or eyes
🚨 Dark urine
🚨 Severe weakness
Tell your doctor about all prescription medicines, OTC medicines, supplements, and herbal products you take.
Tolvaptan is metabolized by CYP3A4, so medicines that strongly affect this enzyme can significantly alter Tolvaptan levels.
Your doctor may need to review:
🔹 Strong CYP3A4 inhibitors
🔹 CYP3A4 inducers
🔹 Other medicines affecting kidney function
🔹 Medicines affecting fluid or electrolyte balance
Do not start or stop medicines without professional advice.
Your doctor may monitor:
🧪 Liver function
🩸 Serum sodium
🫘 Kidney function
💧 Hydration status
🩺 Blood pressure and overall clinical status
For patients with ADPKD, ongoing assessment of kidney function and disease progression is particularly important.
⭐⭐⭐⭐⭐ “The medicine was securely packed and arrived in good condition. The ordering process was convenient.”
— Ahmed K., Lahore 📍
⭐⭐⭐⭐⭐ “Good packaging and smooth delivery. The product arrived safely as expected.”
— Usman R., Islamabad 📍
⭐⭐⭐⭐⭐ “The medicine was properly packed and the online ordering experience was convenient.”
— Hassan M., Karachi 📍
Sample/placeholder reviews for product-page presentation.
TOLVAPTAN 45MG TABLET by CCL PHARMA contains Tolvaptan 45MG, a selective vasopressin V2-receptor antagonist.
Tolvaptan promotes free-water excretion and has an important role in selected patients with rapidly progressing ADPKD. It can also be used for specific forms of hyponatremia, but the dosing regimen differs by indication.
Because of its potential effects on liver function, hydration, and electrolyte levels, Tolvaptan requires appropriate medical supervision and monitoring.
⚠️ Prescription medicine – use only as directed by your nephrologist or other qualified healthcare professional.
✔️ TOLVAPTAN contains Tolvaptan, which is used in selected patients with autosomal dominant polycystic kidney disease (ADPKD) to slow disease progression. Tolvaptan also has specific uses in certain cases of hyponatremia, with different dosing.
✔️ Tolvaptan blocks vasopressin V2 receptors in the kidneys. This increases free-water excretion and, in ADPKD, can interfere with signaling pathways involved in kidney-cyst growth.
✔️ Tolvaptan intentionally increases the removal of free water through the kidneys. As a result, increased urination and thirst are common effects of treatment.
✔️ Yes. Tolvaptan can cause liver injury, particularly during long-term ADPKD treatment. Your doctor may arrange regular liver-function testing and will advise you about warning symptoms.
📢 TOLVAPTAN 45MG TABLET by CCL PHARMA is available through SuperCare Pharma, subject to availability and applicable prescription requirements.
🏆 Trusted Online Pharmacy & Healthcare Store in Pakistan
💊 Genuine Pharmaceutical Products
📦 Secure Packaging
🚚 Nationwide Delivery
💰 Competitive Online Prices
📞 Customer Support for Orders & Product Queries
Looking for Tolvaptan 45MG tablets in Pakistan?
Order TOLVAPTAN 45MG TABLET by CCL PHARMA from SuperCare Pharma for convenient online ordering and reliable delivery.
💙 TOLVAPTAN 45MG | TOLVAPTAN TABLET | CCL PHARMA
⚠️ Prescription medicine – use only under the supervision of a qualified healthcare professional.
